Enhanced HIV-1 neutralization by antibody heteroligation.
Mouquet H, Warncke M, Scheid JF, Seaman MS, Nussenzweig MC. Enhanced HIV-1 neutralization by antibody heteroligation. Proc. Natl. Acad. Sci. 2012, 109(3): 875-80.
[Article]
Center for Virology and Vaccine Research
3 Blackfan Circle
Boston, MA 02115 – USA
T 617.667.7000
F 617.735.4566
E CVVRcontact@bidmc.harvard.edu
CVVR Clinical Trials Unit
T 617.735.4610
E CVVRtrials@bidmc.harvard.edu